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1. Introduction
1.1. Aortic stenosis
Aortic stenosis is characterized by the abnormal narrowing of the aortic valve (AV) opening,
producing a blockage of the blood flow from the left ventricle into the aorta. Two different
types of aortic stenosis can be distinguished. In congenital aortic stenosis an inherited abnor‐
mal formation of the AV exists. Otherwise, in acquired aortic stenosis external causes such as
rheumatic fever or valve degeneration occur. Calcific aortic stenosis (AS) is the most common
valvular disease in elder population and remain the main cause of aortic valve replacement in
developed countries [1].
AS progresses from a primary stage of aortic sclerosis, with thickening and stiffness of the AV,
to severe calcific stenosis. Its most common symptoms are dyspnea, angina and syncope, which
predict the rapid deterioration of left ventricular function, the development of heart failure
and, if the pathology progresses, the patient's death. Therefore, the appearance of any of these
symptoms is considered as an indication for the treatment of this pathology. In these cases,
surgery is recommended to replace the AV since there is not treatment to delay the progression
of the disease.
Classically, this disease has been considered as a consequence of the aging process of the valve.
However, recent studies have provided evidences that inflammation plays a key role in the
physiopathology of AS as well as classical cardiovascular risk factors such as hypertension,
hypercholesterolemia, diabetes, smoking, age or sex [2]. Degeneration of the valve begins with
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an endothelial dysfunction in the aortic side as a result of the abovementioned risk factors.
Low density lipoproteins (LDLs) are accumulated in the subendothelial space of the valve,
where they are oxidized, resulting in the activation of the endothelial cells. These cells express
adhesion and chemotactic molecules, which attract inflammatory cells such as monocytes and
T lymphocytes. Monocytes extravasate to the fibrous layer and differentiate into macrophages,
which capture oxidized lipoproteins and become foam cells. Proinflammatory cytokines
released by both cell types induce phenotypic differentiation of a subset of myofibroblasts to
osteoblasts, which leads to the subsequent formation of calcium nodules [3]. These numerous
similarities suggest a common relationship between atherosclerosis and AS.
1.2. Proteomic and metabolomic study of healthy valves
A complete knowledge of the structures involved in a disease it is important to understand its
development. Previously, healthy tissue such as vasculature and myocardial have been
succesfully studied to better understand the molecular mechanisms involved in vascular
develepment and angiogenesis as well as biochemical changes that occur during physiological
ageing [4, 5].
Histologically, AV consists of three layers: fibrosa, spongiosa and ventricularis. The fibrosa is
located in the aortic side of the leaflets and it is mainly composed of fibroblasts and collagen
fibers. The spongiosa is located below and it is formed by fibroblasts, mesenchymal cells and
a polysaccharides-rich matrix. The ventricularis, found in the ventricular side of the leaflet, is
made up of elastic fibers radially distributed. The AV is externally covered by several layers
of endothelial cells. Collagen is responsible for the mechanical integrity of the valve, the
spongiosa serves as a shock absorber and elastic fibers contract cusps during systole [3, 6].
However, it is also essential to perform studies at the molecular level of the tissue, looking for
the discovery of tissue- and disease-specific markers. For this purpose, proteomic and
metabolomic analyses can be ideally used since they allow the unbias analysis of hundreds or
thousands of molecules at a time, detecting and identifying which molecules are present. In
contrast to genomics and transcriptomics, proteomics and metabolomics study dynamic
protein products, low molecular weight compounds and their interactions, which have a direct
effect on the phenotype of the tissue (Figure 1).
Descriptive proteomics is a methodology that enables unbiased large-scale study of the set of
all proteins in a biologic system at any given time. Thus, the expression, localization, interac‐
tion, structural domains and activity of these proteins, including splice isoforms and post-
translational modifications (PTMs), can be studied [7]. Metabolomics is the study of a complete
metabolome or a single group of particular metabolites, which are small molecules that
participate in general metabolic reactions and that are required for the maintenance, growth
and normal function of a cell [8]. The study of healthy valves through proteomic and metab‐
olomic approaches and the subsequent integration of data, can provide molecular level
information of the metabolic pathways that are more active in that tissue and will help to
understand the mechanisms of physiological/pathological processes in aortic stenosis valves.
This makes it easier the search for potential markers for early diagnosis of the disease, thus
being able to predict which people may develop aortic stenosis in the future.
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2. Proteomics
Proteomics is the large-scale study of the proteins content in a given sample (ie. biofluid or
tissue) [9]. Since proteins are the final product of genes expression, proteomics constitutes a
powerful tool for the study of biological systems thanks to proteome reflects the current state
of the organism and it varies according to its functional situation [10]. These studies can be
performed through a wide variety of techniques and methodologies, depending on the sample
and the experimental design. In the case of descriptive proteomics, in which the most usually
is the study of very complex samples, it is essential to perform certain steps to facilitate the
study: 1) sample preparation, 2) protein separation and 3) analysis by mass spectrometry.
2.1. Sample preparation
Preparation of the samples prior to the analysis using proteomic techniques is an essential step
for obtaining robust and reproducible data. Between the large number of standardized
protocols, the selected one must be carefully chosen to suit the sample to be analyzed, as well
as for the proteins of interest. In the case of the AV an effective and suitable protocol has been
previously described [11] (Figure 2). Briefly, within 2 hours after surgery, valves were washed
in PBS and then ground into a powder in liquid N2 with a mortar. 0.2 g of this powder was
resuspended in 400 μl of protein extraction buffer (Tris 10 mM [pH 7.5], 500 mM NaCl, 0.1%
Triton x-100, 1% β-mercaptoethanol, 1 mM PMSF) and then centrifuged to precipitate mem‐
branes and tissue debris [12]. Supernatant containing most of the soluble proteins was collected
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Figure 1. Dynamic study of the physiophatology of a disease through “-omics” technologies.
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and pellet was solubilized in 7M urea, 2M thiourea, 4% CHAPS prior to another centrifugation
[13, 14]. This second supernatant, which was rich in hydrophobic proteins, was also collected
and stored at -20°. Depending on which is the fraction of interest, supernatants can be analyzed
together or separately. Because of the nature of the extraction buffers, sample must be
processed to eliminate interference substances with the downstream analyses. Samples must
be filtered by centrifugation and dialyzed against Tris 2mM. Before proteomic analyses it is
also recommended the use of the commercial kit 2D-Clean-Up (GE Healthcare), which
precipitates proteins while leaving interfering substances, such as detergents, salts, lipids,
phenolics, and nucleic acids, in solution. The pellet can then be solubilized in a proper buffer
for further analyses.
Instead of solubilized the proteins of whole tissue, histology sections or specific cell types can
be used for isolate different structures of the tissue as regions, cells or even subcellular fractions
by means of laser microdissection (LMD) [15]. It consists in cutting microscopically selected
tissue by laser using different systems [16]: 1) selected regions are transferred onto a film or to
a special cap; 2) selected regions can be catapulted into a collection tube and 3) cut samples
fall down into the lid of a collection tube by gravitation. The collected tissue has to be lysed
and prepared for downstream analyses. The main disadvantage of this methodology in
combination with proteomics is the scarce amount of protein that can be obtain, since the laser
cannot be applied for a long time in order to avoid protein degradation. However, mass
spectrometers have exponentially improved their sensitivity, so there are several interesting
studies combining LMD and Proteomics in other cardiovascular tissues samples [17-20]. The
application of LMD to the analysis of the AV tissue could provide specific data from the
different layers/structures in the tissue, as well as from the behavior of the different cells in the
tissue.
2.2. Protein separation
For complex mixtures, it is important to separate proteins according to their different charac‐
teristic to increase the efficiency of the study. For this purpose, the most usually used techni‐
ques are 2-dimensional electrophoresis (2-DE), off-gel fractionation, and 2-dimensional liquid
chromatography (LC) [21-23] (Figure 3).
2.2.1. 2-Dimensional electrophoresis
This method stands out for its high applicability to a wide range of biological samples. In this
case, a good protein separation can be reached through two simple steps: isoelectric focusing
(IEF) and sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) [24, 25].
During the first phase, the protein mixture is separated on a pH gradient according to their
isoelectric point (pI) using commercial strips covered by an acrylamide gel. To perform this
separation, proteins are completely solubilized in a special buffer containing urea, a nonionic
detergent (CHAPS) to prevent clustering, a reducing agent (DTT) to break the disulfide bonds
and a mixture of ampholytes to minimize aggregations by charge interaction. In the second
step, proteins are separated in a second dimension depending on their molecular mass and a
two-dimensional protein spot map is obtained that can be visualized through different staining
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techniques as Coomassie blue, silver staining and Sypro Ruby [26]. Stained gels are scanned
and digitalized using different computer programs to obtain an image of the gel and spots of
interest will be identified by mass spectrometry techniques. There are three protein groups
which are problematic: highly alkaline, extremely high and low molecular sizes and mem‐
brane-bound proteins. However, improving protein solubilization, pre-fractionation of
protein groups of interest prior to 2DE, or adjustments to the 2-DE regime enhance separation
of these more difficult-to-resolve proteins. The main advantage of 2-DE is that it delivers a
map of intact proteins, which reflects changes in protein expression level, isoforms or post-
translational modifications [27].
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Figure 2. Protocol of aortic valve preparation for proteomic analyses
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Figure 3. Most common used protein separation techniques
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2.2.2. Off-gel fractionation
There is another protein fractionation technique which is based on off-gel IEF, where the
proteins are separated according to their pI in a multiwell device. This separation is based on
immobilized pH gradient (IPG) strips and permits to separate peptides and proteins according
to their pI, but is realized in solution without the need of carrier ampholytes or buffers [28,
29]. The main advantage of this technique is that the fractions can be directly recovered in
solution for further analysis and directly digested if necessary [28, 30]
2.2.3. Liquid chromatography
Liquid chromatography (LC) is a fractionation technique that can be applied to separate a wide
range of molecules such as proteins or peptides according to their physical and/or chemical
properties. Different types of chromatographic support can be distinguished: ion exchange
(separation based on protein or peptide charge), reverse phase (according to their polarity),
affinity (based on a highly specific interaction such as that between antigen and antibody,
enzyme and substrate, or receptor and ligand) and molecular exclusion (depending on size).
LC can be used before or after 2-DE [31-33] and can be directly coupled to a mass spectrometer
for further identification [34, 35]. To increase the resolution of proteomics analyses, it is
recommended the use several consecutive chromatographic methods. In this sense a combi‐
nation of ion exchange and reverse phase chromatography allows a two-dimensional separa‐
tion with the advantage that the second column can be directly coupled to MS, which enhances
the automatization of the proteomic methodology. With this idea, multidimensional protein
identification technology (MudPIT) has been developed. It consists of a column with two
chromatographic supports in tandem: a cation exchange support in the proximal area followed
by a reverse phase in the distal one. This method enables the two-dimensional LC using high-
performance LC (HPLC) coupled to a mass spectrometer with electrospray ionization (ESI)
source in an automated manner [36, 37]. This approach is more sensitivity and reproducibility
than gel-based methodologies and allows the analyses of smaller quantities each time because
of the development of new equipments which are able to work with sample volumes of the
order of microliters and nanoliters. LC together with mass spectrometry has been successfully
employed in a previous work in which the proteome of the coronary artery was described [17].
2.3. Protein analyses by mass spectrometry
Once our sample is separated, these fractions or spots must be analyzed to identify the different
proteins. Since the development of matrix-assisted laser desorption ionization (MALDI) and
ESI, two ionization methods that allows the analysis of proteins and peptides using MS, this
technique have become indispensable for protein identification [38-40]. Mass spectrometers
consist of three essential elements: ionization source, mass analyzer and detector (Figure 4).
The ionization source ionizes and vaporizes the sample. Different ionization sources are
MALDI, ESI or surface-enhanced laser desorption/ionization (SELDI) [41-43]. ESI allows the
identification of many volatile and thermolabile compounds of a wide range of molecular
weight with high sensitivity. MALDI and SELDI are very similar methods but they are used
for low and high complex mixtures, respectively [44]. The mass analyzer separates the ions
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according to their relation m/z. There are also different types of mass analyzer, such as
quadrupole (Q), time of flight (TOF), ion trap (IT), Fourier transform ion cyclotron resonance
(FT-ICR) and Orbitrap. The ion stream reaches to the detector and it is transformed into an
electrical signal. These signals are then integrated by a computer system which generates a
mass spectrum which represents the abundance of the different generated ions.
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Figure 4. Different elements of a mass spectrometer
There are two different ways to identify the molecules included in a complex mix using MS:
peptide mass fingerprinting (PMF) and tandem mass spectrometry (MS/MS or MS2). Briefly,
identification based on PMF identifies proteins according to the peptides generated after
digestion with specific endoproteases, usually trypsine. Experimentally obtained peptide
masses are compared to theoretical peptide masses of proteins stored in databases through
mass search engines such as MASCOT (Matrix Science Ltd.) [45], MS-Fit [46] or Profound [47,
48]. These samples usually come from gel bands, 2-DE spots or LC fractions with low com‐
plexity and are analyzed through MALDI-TOF or ESI-TOF [48, 49]. In the case of MS/MS, two
mass analyzers are used in tandem. The first one allows the measurement of the m/z values
of the peptides and the second one, after the fragmentation of some peptides, allows the
measurement of the m/z values of these fragments. Thus, a partial or even total sequence of
the peptide can be obtained. Most usually used mass spectrometer for this purpose are MALDI-
TOF-TOF (for low complex mixtures) and ESI coupled to different analyzers (Q3, Q-TOF, IT,
Q-Q-LIT, FT y Orbitrap).
2.4. Tissue sections analysis: MALDI imaging mass spectrometry
MALDI imaging mass spectrometry (IMS) is a powerful tool for investigating the distribution
of proteins and small molecules present in thin tissue sections. This technique generates
molecular profiles and two-dimensional ion density maps of peptide and protein signals
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directly from the surface of these sections [50]. For this analyses, it is indispensable a correct
sample preparation in terms of chemical and structural integrity [51]. Preparation methods
must avoid delocalization and degradation of the analytes so it is important to take into account
several parameters such as treatment of tissue immediately after sample procurement,
sectioning, sample transfer to the MALDI target plate, matrix application, and tissue storage
after sectioning [52]. It is advisable the used of fresh tissue sections though sometimes it is
necessary embedding the sample in gelatine or agarose to facilitate its manipulation [53-55].
One of the important aspects of tissue profiling is the comparison of histological features
obtained from stained sections using light microscopy with molecular images obtained by
mass spectrometry [56]. Previously, this was accomplished using two separate adjacent
sections, one for histology and one for MALDI-IMS [57, 58]. However, visual registration
between both sections it is difficult because of differences in tissue architecture. Ideally,
histology and protein profiling should be performed on the same tissue section. For this reason,
several commonly used histological dyes have been tested for compatibility with MS analysis.
It was found that hematoxilin and eosin interfered with MS but, on the other hand, cresyl violet
and methylene blue, between others, do not compromise mass spectra quality [56]. This
methodology allows the study of the entire tissue, maintaining its structure, so MS analysis
can be focused on specific morphological regions of interest.
3. Metabolomics
Metabolomics is the study of the set of final products and by-products of many metabolic
pathways, called metabolites, which exist in humans and other living systems [8]. In order to
perform a descriptive analysis of healthy valves, an untargeted approach, not focused on a
specific group of metabolites, is the most recommended methodology. This method, also called
metabolomic fingerprinting, permits to detect the largest number of metabolites optimizing
different experimental conditions such as sample preparation and chromatographic and MS
parameters. This approach usually compromises the sensitivity and specificity for identifica‐
tion of individual metabolites [59, 60]. Additionally, metabolomic fingerprinting involves less
up-front method development when compared with targeted approaches but requires an
exhaustive analysis due to the large number of identified metabolites. As well as in proteomics
analyses, there are three main steps when performing a metabolomic study: [1] sample
preparation; [2] metabolite detection and [3] data analysis.
3.1. Sample preparation
Optimization of sample-preparation protocol is extremely important in metabolomic studies
because it affects both metabolite profile and quality data, leading to possible erroneous
conclusions [61, 62]. An ideal sample-preparation method for metabolomic fingerprinting
should have the following characteristics [1] non-selective to ensure adequate metabolite
coverage; [2] simple and fast, with the minimum number of steps possible to minimize
metabolite loss and/or degradation of the sample and enable high-throughput; [3] reproduci‐
ble and [4] incorporate a metabolism-quenching step (low temperatures, addition of acid, or
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fast heating) to represent true metabolome composition at the time of sampling (Figure 5) [63].
For tissue metabolomics, the protocol includes a previous step of manual homogenization at
low temperatures follow by a quenching step in liquid nitrogen [64]. Although the tissue
disruption technique can altered the precision and metabolite coverage, the selection of the
extraction solvent have a stronger effect on the number of extracted metabolites [65]. Several
aqueous and organic solvents can be used, such us methanol [66, 67], methanol/water [68],
isopropanol/acetonitrile/water [69], acetonitrile/methanol/water [70], acidic acetonitrile/water
[71] or methanol/acetonitrile/acetone [72] between others. However, there is no an established
protocol for aortic valve so it is important the development of an adequate method before
metabolic fingerprinting.
Supernatant
Extraction
solvent
Quenching: 
Liquid
nitrogen
METABOLOMIC
ANALYSIS
Ideal Sample Preparation
Method
Non-selective
Simple and fast
Reproducible
Metabolism-quenching step
Figure 5. Protocol of tissue preparation for metabolomic analyses.
3.2. Metabolite detection
There is a great variability of metabolites in terms of polarity, solubility, and volatility with a
wide dynamic range of concentration in biological samples. Therefore it is necessary to
combine different chromatographic platforms for covering the largest range of metabolite
possible. The two main platforms used in metabolomics analysis are nuclear magnetic
resonance (NMR) and MS, usually coupled with a separation method for metabolites (LC or
gas chromatography (GC)-MS) [73, 74]. The platform of choice will depend on the physico‐
chemical characteristics of the metabolites of interest. As it is explained below, CG-MS is a
high-quality technique for analyzing hydrophobic compounds while LC-MS permits to
determine a larger number of metabolites. Finally, NMR shows superior capability for
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determining the structure of unknown metabolites. Therefore, each platform has inherent
advantages and disadvantages for the metabolomic analysis of different compounds and only
through their combined use the best understanding of the physiopathology of AV will be
achieved (Table 1).
Advantages PLATFORM Disadvantages
Minimal sample preparation
Non-destructive
Reproducible
Structural information
NMR SensitivitySpectral resolution
No derivatization required
Variety of metabolites LC-MS No comprehensive spectral libraries
Sensitivity
Robust
Reproducible
Comprehensive spectral libraries
CG-MS Derivatization requiredLimited mass range
Table 1. Comparison of the most common analytical methods used for metabolomics
3.2.1. Nuclear magnetic resonance
NMR is a spectroscopic analysis technique that exploits the specific magnetic spin or resonance
frequency of the protons within atomic nuclei of specific molecules. When nuclei in a magnetic
field are exposed to a radiofrequency pulse their protons temporarily move to a higher energy
state, and then release a characteristic radiowave when they return to their normal energy state
[75]. The resulting NMR spectrum is a collection of characteristic peaks and intensities of each
compound that allow its identification [76]. NMR requires minimal sample preparation, it is
a nondestructive and very reproducible technique and provides structural information of
metabolites. These particular advantages confers NMR superior ability for the identification
of unknown metabolites and constitutes a valuable approach for identification of unknown
metabolites [77]. However, NMR is limited in terms of sensitivity and spectral resolution so it
is not a good technology to identify metabolites that are found in low concentration [78].
NMR also allows the analyses of intact tissue using a technique called high-resolution magic
angle spinning (HRMAS) NMR. The sample is spun at high speed about an axis at an angle of
54°44′(the so-called “magic angle”) [79]. This rapid spinning at this precise angle has the effect
of reducing dipolar coupling effects and narrowing of the broad lines found in this tissue.
HRMAS-NMR has been applied successfully to analyze different intact cells and tissues
[80-85], so it seems to be a powerful tool for the analyses of aortic valve tissue.
3.2.2. Mass spectrometry
As well as in proteomic studies, MS uses m/z value to identify metabolites. When coupled with
chromatographic methods, MS can analyze a wide number of metabolites with enhanced
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sensitivity. The two main strategies for metabolite separation are LC (for nonvolatile com‐
pounds in solution) or GC (for volatile samples or when the expected compounds can be easily
made volatile by derivatization). LC-MS using ESI as ionization source is the most currently
used platform for metabolomic studies since it permits the analysis of a wider variety of
metabolites than GC-MS [86, 87]. Also, derivatization step prior the analysis is no necessary
reducing losses of compounds during the sample preparation. Single quadrupole, ion trap and
TOF analyzers are the most commonly used mass analyzers. GC-MS is a first-rate choice for
the analysis of volatile compounds such as fatty acids and organic acids [88]. In most cases, it
is necessary a prior step for chemical derivatization of non-volatile and thermally stable
metabolites. The two more used derivatization reagents include BSTFA (N, O-Bis (trimethyl‐
silyl) trifluoroacetamide) and MSTFA (N-Methyl-N-(trimethylsilyl) trifluoroacetamide)
[89-91]. Advantages of GC include higher resolution and more robust and reproducible
retention times than LC, besides the existence of mass spectral libraries, which facilitates the
identification process.
In the course of the study of the physiopathology of AS the better comprehension of implicated
and altered biochemical pathways will be acquired through the metabolomic study of
biological samples, specially plasma and tissue. For this purpose NMR and MS represent the
two most valuable techniques for metabolite identification thus the information that both
techniques provide will suppose a cornerstone for the study of this disease.
3.3. Identification and data analysis
The data processing challenges in metabolomics are quite unique and often require specialized
(and/or expensive) data analysis software and a complete knowledge of cheminformatics,
bioinformatics and statistics for a correct interpretation of data. Ideally, data analysis softwares
must be able to remove noise from the spectra, properly identify which metabolite generates
every chromatographic peak and make a correct alignment of the peaks corresponding to the
same compound in several successive samples [92, 93].
There are several commercial softwares available free such as MSFacts, MetAlign or Metab‐
oAnalyst which automatically import, reformat, align, correct the baseline, and export large
chromatographic data sets to allow more rapid visualization of metabolomics data [94, 95].
However, most companies usually generate data that can be only read with own softwares
which use mass spectral libraries for peak detection, identification and integration [96].
4. Towards a global understanding of physiology
The large number of genomes, including human, that have been mapped and the knowledge
of the genetic code, have increased the interest in other –OMICS technologies, such as
proteomics and metabolomics. Both proteomics and metabolomics differ from genomics in
terms of complexity and dynamic variability. Proteome and metabolome are constantly
changing according to the genome and the environment, therefore the ultimate phenotype of
cell, organ, and organism is reflected in proteomic and metabolomic profiles. This variability,
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enhanced by the using of different methodologies and equipments, usually impedes obtaining
reliable and reproducible results when comparing patients and healthy controls. The study of
a large number of healthy valves using a standardized protocol may provide useful informa‐
tion about the heterogeneity of its profiles. Thus, different profiles could be assigned to
different states such as sex, age or risk factors. This way, the creation of a protein atlas
unmasking the expression and localization of proteins coupled to metabolomic results would
function as a global knowledgebase with valuable information about normal cellular function
[97, 98]. All these information can be storage in conventional web-based databases, in order to
obtain a reference material to be used in further studies, when studying different valve
diseases, helping to deepen the understanding of the beginning and development of the
disease. It would also be possible to find some variation involving metabolic predisposition
to develop the disease in the future. This will exponentially increase the possibilities to discover
potential therapeutic targets and will open the door to develop a personalized medicine in this
disease.
The major challenge of generating a complete database of AV tissue is obtaining enough
biological material to be described, since it is not an easily accessible specimen. It is necessary
a complex coordination of basic research activities, facilities and infrastructures, as well as the
creation of an integrated and multidisciplinary environment with the participation of several
different specialists in cardiovascular diseases, i.e. basic researchers, cardiologists, surgeons,
pathologists, epidemiologists, patients, patient advocacy groups, funding agencies and
industrial partners. Issues related to sample collection, handling and storage, standardization
of protocols, common references, number of patients, availability of normal controls, access to
bio-banks, tissue arrays, clinical information, follow-up clinical data, computational and
statistical analysis, as well as ethical considerations are critical, and must be carefully consid‐
ered and dealt with from the beginning [99]. With such a big collaborating work, there will be
a more effective translation of basic discoveries into clinical applications.
No matter how much ambitious and complete the descriptive study is, it is essential integration
of the results through a system biology approach. This consists of placing proteins and
molecules from experimental analysis in the context of a network of biological interactions,
such as gene–gene, gene–protein or protein–protein interactions, followed by different ‘guilt-
by-association’ analyses [100]. Usually, these networks are deduced from previously published
interactions or from computational prediction models. Different tools exist to perform these
analyses, most of them based on Cytoscape Web, a freely available network visualization tool
for integrating biomolecular interaction networks with high-throughput expression data and
other molecular states into a unified conceptual framework [101-103]. Using an integrative
approach, we can obtain a more holistic picture of the molecular mechanisms that occurs in
normal aortic valves.
5. Conclusion
The study of healthy valves through proteomic and metabolomic approaches and the subse‐
quent integration of data can provide molecular level information of the metabolic pathways
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that are more active in AV. The characterization of physiological proteins and metabolites in
this tissue and the creation of a complete database with the results from the descriptive studies,
may serve as a reference material for further studies. This would facilitate the searching for
potential markers for early diagnosis of the disease, thus being able to predict which people
may develop aortic stenosis in the future.
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